Contents

Search


placental growth factor; PlGF (PGF, PGFL, PLGF)

Function: - growth factor active in angiogenesis & endothelial cell growth, stimulating their proliferation & migration. - controls blood vessel formation & permeability through interactions with two endothelial tyrosine kinase receptors: FLT1 & KDR/FLK1 - PlGF-2 binds NRP1/neuropilin-1 & NRP2/neuropilin-2 (heparin-dependent) - forms heterodimer with VEGFA/VEGF - isoform PlGF-3 is found both as homodimer & as monomer Structure: - N-glycosylated - antiparallel homodimer; disulfide-linked - isoform PlGF-2 contains a basic insert which acts as a cell retention signal - belongs to the PDGF/VEGF growth factor family Compartment: - secreted - PlGF-2 appears to remain cell attached unless released by heparin Alternative splicing: - named isoforms=3; PlGF-1, PlGF-2, PlGF-3 Expression: - present in most placental tissues - PlGF-2 is specific to early (8 week) placenta - only PlGF-1 is found in the colon & mammary carcinomas Pathology: - plasma placental growth factor levels are decreased in women with pre-eclampsia [2] Laboratory: - placental growth factor in serum

Related

vascular endothelial growth factor receptor 1; VEGFR-1; vascular permeability factor receptor; tyrosine-protein kinase receptor FLT; Flt-1; tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1 (FLT1, FLT, FRT) vascular endothelial growth factor receptor 2; VEGFR-2; kinase insert domain receptor; protein-tyrosine kinase receptor Flk-1; CD309 (KDR, FLK1)

General

glycoprotein growth factor

Properties

SIZE: entity length = 221 aa MW = 25 kD MOTIF: signal sequence {1-18} N-glycosylation site {N33} cysteine residue {C52} MODIFICATION: cysteine residue {C94} cysteine residue {C77} MODIFICATION: cysteine residue {C-INTERCHAIN} cysteine residue {C83} MODIFICATION: cysteine residue {C128} cysteine residue {C86} MODIFICATION: cysteine residue {C-INTERCHAIN} cysteine residue {C87} MODIFICATION: cysteine residue {C130} cysteine residue {C94} MODIFICATION: cysteine residue {C52} N-glycosylation site {N101} cysteine residue {C128} MODIFICATION: cysteine residue {C83} cysteine residue {C130} MODIFICATION: cysteine residue {C87} binding site SITE: 193-213 FOR-BINDING-OF: heparin

Database Correlations

OMIM 601121 UniProt P49763 Pfam PF00341 Entrez Gene 5228 Kegg hsa:5228

References

  1. UniProt :accession P49763
  2. Zeisler H et al Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016; 374:13-22. January 7, 2016 PMID: 26735990 http://www.nejm.org/doi/full/10.1056/NEJMoa1414838 - Seely EW, Solomon CG Improving the Prediction of Preeclampsia N Engl J Med 2016; 374:83-84. January 7, 2016 PMID: 26735997 http://www.nejm.org/doi/full/10.1056/NEJMe1515223